Episalvan® is a prescription pharmaceutical product which has been demonstrated to accelerate wound healing in adult patients with partial thickness wounds (PTW). It’s approved in Europe for the treatment of PTWs in adults. Such wounds include burns, split thickness skin graft (STSG) donor sites, dermatological and aesthetic procedures, decubitus ulcers (stage II), toxic epidermal necrolysis and radiation and drug side effects.

Episalvan® is a topical product which is formulated to contain two ingredients, its betulin-based active ingredient and sunflower oil as the only excipient.

Email Alerts

Subscribe to Our Newsletter:

Delivered by Investis – link to website (opens in a new window)